In a large cohort of patients with transfusion-dependent β-thalassemia, we demonstrate an association between ascending pretransfusion hemoglobin levels starting at 9.5 g/dL and reduced mortality risk.

Subjects:
Clinical Trials and Observations
This content is only available as a PDF.
Copyright © 2023 American Society of Hematology
2023

Article PDF first page preview

Article PDF first page preview
You do not currently have access to this content.
Sign in via your Institution